The information highlighted (if any) are the most recent updates for this brand.
Soliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT2 inhibitors, when this has not been provided by metformin alone or metformin combined with another oral glucose lowering medicinal product (sulfonylurea, glinide, DPP-4 inhibitors or gliptins, and Sodium-glucose co-transporter 2 (SGLT2) inhibitors or gliflozin) or with basal insulin or with a GLP-1RA (see Precautions and Pharmacology: Pharmacodynamics under Actions for available data on the different combinations).
Sign Out
